Yu-Ting Huang
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
2020/10/01 by Patrick A. Ott, Siwen Hu‐Lieskovan, Siwen Hu-Lieskovan +44 · 11 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses #vaccines and immunoinformatics approaches
- Author response to OSIN-D-26–01484: “Clarifying statistical methods in a TriNetX analysis of statins and osteoporosis in CKD patients”
2026/07/29 by Ping-Hsun Wu, Yi-Ting Lin, Jian-Chih Chen +6